Brian Duffy Sells 1,468 Shares of Atlassian (NASDAQ:TEAM) Stock

Atlassian Corporation PLC (NASDAQ:TEAM) CRO Brian Duffy sold 1,468 shares of the company’s stock in a transaction on Friday, November 14th. The shares were sold at an average price of $152.46, for a total transaction of $223,811.28. Following the sale, the executive directly owned 128,476 shares in the company, valued at $19,587,450.96. This trade represents a 1.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Atlassian Stock Up 1.9%

Shares of Atlassian stock opened at $148.75 on Wednesday. The stock’s 50-day moving average is $160.32 and its 200 day moving average is $182.84. Atlassian Corporation PLC has a one year low of $144.32 and a one year high of $326.00. The firm has a market cap of $39.14 billion, a price-to-earnings ratio of -209.50, a PEG ratio of 34.63 and a beta of 0.95. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.26 and a quick ratio of 1.26.

Atlassian (NASDAQ:TEAM) last issued its quarterly earnings results on Thursday, October 30th. The technology company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.21. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.40 billion. Atlassian had a negative return on equity of 7.11% and a negative net margin of 3.38%.The company’s revenue was up 20.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.77 earnings per share. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts anticipate that Atlassian Corporation PLC will post -0.34 EPS for the current year.

Hedge Funds Weigh In On Atlassian

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Capco Asset Management LLC purchased a new stake in shares of Atlassian during the second quarter valued at approximately $25,000. Physician Wealth Advisors Inc. increased its position in shares of Atlassian by 60.4% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after purchasing an additional 61 shares during the last quarter. Atlantic Union Bankshares Corp increased its position in shares of Atlassian by 19,900.0% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after purchasing an additional 199 shares during the last quarter. Smithfield Trust Co raised its stake in shares of Atlassian by 90.7% during the 1st quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock worth $34,000 after purchasing an additional 78 shares during the period. Finally, Geneos Wealth Management Inc. grew its position in Atlassian by 447.2% during the first quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock valued at $42,000 after buying an additional 161 shares during the period. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Analysts Set New Price Targets

TEAM has been the subject of several research reports. Wells Fargo & Company assumed coverage on Atlassian in a research note on Tuesday, September 30th. They issued an “overweight” rating and a $216.00 target price for the company. Sanford C. Bernstein boosted their target price on shares of Atlassian from $290.00 to $304.00 and gave the stock an “outperform” rating in a research report on Tuesday. Zacks Research upgraded shares of Atlassian from a “strong sell” rating to a “hold” rating in a report on Monday, November 3rd. Cantor Fitzgerald reiterated an “overweight” rating and set a $240.00 price target on shares of Atlassian in a research note on Friday, October 31st. Finally, BMO Capital Markets increased their price objective on Atlassian from $190.00 to $195.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Atlassian has a consensus rating of “Moderate Buy” and an average price target of $240.00.

Atlassian Company Profile

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.